Naar homepage     
Chronische Cerebro-Spinale Veneuze Insufficiëntie
Aanmelden op het CCSVI.nl forum
Lees Voor (ReadSpeaker)    A-   A+
Over CCSVI.nl | Zoeken | Contact | Forum
CCSVI.nl is onderdeel van de
Franz Schelling Website
meer informatie
  
Saturday, December 4, 2010 9:20 PM | Ken Torbert Volg link

These are two of the papers presented at ECTRIMS 2010--


Here are the abstracts with links for physicians.



The chronic cerebrospinal venous insufficiency syndrome


P Zamboni and R Galeotti


Vascular Disease Centre, Interventional Radiology Unit, University of Ferrara, Italy


Correspondence: P Zamboni MD, University of Ferrara, 44100 Ferrara, Italy. Email:zmp@unife.it



Chronic cerebrospinal venous insufficiency (CCSVI) is a syndrome characterized
by stenosies of the internal jugular and/or azygous veins (IJVs-AZ) with

opening of collaterals and insufficient drainage proved by reduced

cerebral blood flow and increased mean transit time in cerebral MRI

perfusional study. The present review is aimed to give a comprehensive

overview of the actual status of the art of the diagnosis and treatment

of this condition. As far as the origin of venous narrowing is

concerned, phlebographic studies of the IJVs and AZ systems demonstrated

that venous stenoses were likely to be truncular venous malformations;

mostly, they are intraluminal defects such as malformed valve,

septa webs. CCSVI condition has been found to be strongly

associated with multiple sclerosis (MS), a disabling

neurodegenerative and demyelinating disease considered autoimmune in

nature. In several epidemiological observations performed at

different latitudes on patients with different genetic backgrounds,

theprevalence of CCSVI in MS ranges from 56% to 100%. To the

contrary, by using venous MR and/or different Doppler protocols,

CCSVI was not detected with the same prevalence. Two pilot

studies demonstrated the safety and feasibility in Day Surgery of

the endovascular treatment of CCSVI by means of balloon

angioplasty (PTA). It determines a significant reduction of

postoperative venous pressure. Restenosis rate was found out elevated in

theIJVs, but negligible in the AZ. However, PTA seems to

positively influence clinical and QoL parameters of the associated MS

and warrants further randomized control trials.



http://phleb.rsmjournals.com/cgi/content/abstract/25/6/269





Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe?


T Ludyga *, M Kazibudzki *, M Simka * , M Hartel , M wierad *,J Piegza *, P Latacz *, L Sedlak * and M Tochowicz *


EUROMEDIC Specialist Clinics, Department of Vascular & Endovascular Surgery,
Katowice; Magnetic Resonance Imaging Department VOXEL, Medical

University Hospital No 1, Zabrze, Poland


Correspondence: M Simka PhD MD, ul. Jednosci 20, 43-245 Studzionka, Poland. Email:mariansimka@poczta.onet.pl



Objectives: The aim of this report is to assess the safety of endovasculartreatment
for chronic cerebrospinal venous insufficiency (CCSVI). Although

balloon angioplasty and stenting seem to be safe procedures, there are

currently no data on the treatment of a large group of patients with

this vascular pathology.


Methods: A total of 564 endovascular procedures (balloon angioplasty or, if this procedure
failed, stenting) were performed during 344 interventions in 331 CCSVI

patients with associated multiple sclerosis.


Results: Balloon angioplasty alone was performed in 192 cases (55.8%), whereas
the stenting of at least one vein was required in the remaining 152

cases (44.2%). There were no major complications (severe bleeding,

venous thrombosis, stent migration or injury to the nerves) related to

the procedure, except for thrombotic occlusion of the stent in two cases

(1.2% of stenting procedures) and surgical opening of femoral vein to

remove angioplasticballoon in one case (0.3% of procedures). Minor

complications included occasional technical problems (2.4% of

procedures): difficulty removing the angioplastic balloon or problems

with proper placement of stent, and other medical events (2.1%

of procedures): local bleeding from the groin, minor

gastrointestinal bleeding or cardiac arrhythmia.


Conclusions: The procedures appeared to be safe and well tolerated by the patients,
regardless of the actual impact of the endovascular treatments for

venous pathology on the clinical course of multiple sclerosis, which

warrants long-term follow-up.



http://www.facebook.com/note.php?note_id=472445562210&id=110796282297


http://phleb.rsmjournals.com/cgi/content/abstract/25/6/286